News

New research reveals that the protein Dystroglycan plays a critical role in forming and maintaining connections between nerve cells in the cerebellum.

Researchers have successfully grown miniature lungs from stem cells – complete with their own functioning blood vessel networks.

Putting the brakes on an enzyme might rescue neurons that are dying in Parkinson's disease, stabilizing the progression of symptoms.

A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by mitochondrial processes, which can be effectively targeted using existing drugs.

Researchers have developed a bioengineered hydrogel platform capable of preserving patient-derived tumor tissues for longer periods, a breakthrough that could enhance drug testing for abdominal cancer.

Researchers identified a protein that could be targeted to block chronic inflammation. Crucially, this strategy would not interfere with acute inflammation, allowing the immune system to continue responding appropriately to short-term threats.

Researchers have identified two proteins in an organelle specific to Plasmodium falciparum that could be used as drug targets for novel antimalarials.

An oral drug called MA-5 can improve both heart and muscle problems in Barth syndrome. Testing the drug on cells from Barth syndrome patients and in fruit fly models of the disease, the drug boosted cellular energy production by up to 50%.

Targeting the flagellum to deliver a critical, but not fatal, blow to bacteria could help in the fight against antibiotic resistance.

Scientists have developed a new polymer, PHOx, which could significantly improve the safety of implantable medical devices while also being more environmentally friendly.